No impact of KIR-ligand mismatch on allograft outcome in HLA-compatible kidney transplantation

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 1063-1068

  Tran, T H ^a   Unterrainer, C ^a   Fiedler, G ^a   Dohler B ^a   Scherer, S ^a   Ruhenstroth, A ^a   Adamek, M ^a   Middleton, D ^b   Opelz, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Graft survival; HLA; kidney transplantation; KIR

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MYCOPHENOLIC ACID; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HLA TYPING; HUMAN; HUMAN TISSUE; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; GENOTYPE; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; LIGANDS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTORS, KIR; RENAL INSUFFICIENCY; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84875749165     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12134     Document Type: Article

References (27)

1. van Bergen J, Thompson A, Haasnoot GW, et al. KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation. Am J Transplant 2011; 11: 1959-1964.
2. Middleton D, Gonzelez F,. The extensive polymorphism of KIR genes. Immunology 2010; 129: 8-19.
3. Parham P, Norman PJ, Abi-Rached L, Guethlein LA,. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci 2012; 367: 800-811.
4. Campbell KS, Purdy AK,. Structure/function of human killer cell immunoglobulin-like receptors: Lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 2011; 132: 315-325.
5. Cheent K, Khakoo SI,. Natural killer cells: integrating diversity with function. Immunology 2009; 126: 449-457.
6. Gardiner CM., Killer cell immunoglobulin-like receptors on NK cells: The how, where and why. Int J Immunogenet 2008; 35: 1-8.
7. Hanvesakul R, Kubal C, Moore J, et al. KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation. PLoS One 2011; 6: e23631.
8. Kreijveld E, van der Meer A, Tijssen HJ, Hilbrands LB, Joosten I,. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation. Transplantation 2007; 84: 1045-1051. (Pubitemid 350287386)
9. Kunert K, Seiler M, Mashreghi MF, et al. KIR/HLA ligand incompatibility in kidney transplantation. Transplantation 2007; 84: 1527-1533. (Pubitemid 350294729)
10. Nowak I, Majorczyk E, Wisniewski A, et al. Does the KIR2DS5 gene protect from some human diseases? PLoS One 2010; 5: e12381.
11. Stern M, Elsasser H, Honger G, Steiger J, Schaub S, Hess C,. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients. Am J Transplant 2008; 8: 1312-1317. (Pubitemid 351763694)
12. Tran TH, Mytilineos J, Scherer S, Laux G, Middleton D, Opelz G,. Analysis of KIR ligand incompatibility in human renal transplantation. Transplantation 2005; 80: 1121-1123. (Pubitemid 41611937)
13. Vampa ML, Norman PJ, Burnapp L, Vaughan RW, Sacks SH, Wong W,. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch. Transplantation 2003; 76: 1220-1228. (Pubitemid 37339648)
14. Miller SA, Dykes DD, Polesky HF,. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. Mytilineos J, Scherer S, Dunckley H, et al. DNA HLA-DR typing results of 4000 kidney transplants. Transplantation 1993; 55: 778-781. (Pubitemid 23122046)
16. Scherer S, Mytilineos J, Forssmann U, et al. Analysis of rare HLA-DRB1-DQB1 haplotypes in kidney donors and recipients. Transplant Proc 1995; 27: 684-685.
17. Ashouri E, Ghaderi A, Reed EF, Rajalingam R,. A novel duplex SSP-PCR typing method for KIR gene profiling. Tissue Antigens 2009; 74: 62-67.
18. Maxwell LD, Wallace A, Middleton D, Curran MD,. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002; 60: 254-258. (Pubitemid 35398828)
19. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS,. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 2003; 171: 3415-3425. (Pubitemid 37254542)
20. Murphy WJ, Parham P, Miller JS,. NK cells-from bench to clinic. Biol Blood Marrow Transplant 2012; 18 (Suppl): S2-S7.
21. Trundley AE, Hiby SE, Chang C, et al. Molecular characterization of KIR3DL3. Immunogenetics 2006; 57: 904-916. (Pubitemid 43185425)
22. Norman PJ, Carrington CV, Byng M, et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002; 3: 86-95. (Pubitemid 38961114)
23. Cooley S, Trachtenberg E, Bergemann TL, et al. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood 2009; 113: 726-732.
24. Kroger N, Zabelina T, Berger J, et al. Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma. Leukemia 2011; 25: 1657-1661.
25. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100. (Pubitemid 34229476)
26. Rajalingam R, Gebel HM,. KIR-HLA mismatching in human renal allograft transplantation: Emergence of a new concept. Am J Transplant 2011; 11: 1771-1772.
27. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P., Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol 2008; 180: 3969-3979.